Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113105402A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113105402A details a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.